Earnings Feed
Start Free
Home/Insiders/EBERT CHARLES D
EC
SEC Insider//CIK 0001241752

EBERT CHARLES D

CIK 00012417522 companiesCORONA, CA
SEC Profile

Transactions

50

Companies

2

Filings

13

CIK

0001241752

Recent Transactions

50 trades
  • Sale
    Allergan plc

    Ordinary Shares

    2013-11-06$158.75/sh−10,877→ 7,611 total
  • Award
    Allergan plc

    Ordinary Shares

    2013-10-01+18,488→ 18,488 total
  • Disposition to Issuer
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-10-01−18,488→ 0 total
  • Award
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-09-30+12,212→ 32,182 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-09-30$144.00/sh−13,694→ 18,488 total
  • Sale
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-08-05$136.25/sh−8,244→ 19,970 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-08-05$136.25/sh−8,244→ 19,970 total
  • Award
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-03-06+2,653→ 26,487 total
  • Award
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-03-06+1,727→ 28,214 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-03-05$86.46/sh−1,331→ 23,834 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2013-03-02$85.54/sh−1,761→ 25,165 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-03-14$59.21/sh−1,265→ 26,926 total
  • Award
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-03-08+3,342→ 25,625 total
  • Award
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-03-08+2,566→ 28,191 total
  • Sale
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-02-29$58.77/sh−1,000→ 26,264 total
  • Sale
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-02-29$58.81/sh−3,981→ 22,283 total
  • Exercise/Conversion
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-02-29$25.64/sh+1,000→ 27,264 total
  • Exercise/Conversion
    Allergan Finance LLC

    Incentive Stock Options to Purchase Common Stock

    2012-02-29−1,000→ 0 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2012-02-24$58.17/sh−1,458→ 26,264 total
  • Sale
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2011-06-01$64.45/sh−2,635→ 27,722 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2011-03-11$56.89/sh−616→ 30,357 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2011-03-05$56.79/sh−1,295→ 30,973 total
  • Sale
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2011-03-03$56.36/sh−7,500→ 32,268 total
  • Exercise/Conversion
    Allergan Finance LLC

    Non-qualified Options to Purchase Common Stock

    2011-03-03−7,500→ 0 total
  • Exercise/Conversion
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2011-03-03$48.85/sh+7,500→ 39,768 total
  • Award
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2011-03-02+7,119→ 32,268 total
  • Sale
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2010-12-06$51.00/sh−3,639→ 25,149 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2010-09-01$44.15/sh−216→ 28,788 total
  • Tax Payment
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2010-03-14$41.37/sh−1,265→ 29,004 total
  • Exercise/Conversion
    Allergan Finance LLC

    Incentive Stock Options to Purchase Common Stock

    2010-03-12−4,843→ 0 total
  • Exercise/Conversion
    Allergan Finance LLC

    Non-Qualified Options to Purchase Common Stock

    2010-03-12−1,600→ 0 total
  • Exercise/Conversion
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2010-03-12$26.14/sh+8,757→ 51,869 total
  • Sale
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2010-03-12$40.87/sh−200→ 54,919 total
  • Exercise/Conversion
    Allergan Finance LLC

    Non-Qualified Options to Purchase Common Stock

    2010-03-12−8,757→ 3,400 total
  • Exercise/Conversion
    Allergan Finance LLC

    Non-Qualified Options to Purchase Common Stock

    2010-03-12−3,684→ 0 total
  • Exercise/Conversion
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2010-03-12$38.92/sh+1,600→ 31,869 total
  • Exercise/Conversion
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2010-03-12$35.11/sh+3,684→ 55,869 total
  • Exercise/Conversion
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2010-03-12$25.64/sh+1,999→ 58,869 total
  • Exercise/Conversion
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2010-03-12$38.92/sh+6,400→ 38,269 total
  • Exercise/Conversion
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2010-03-12$35.11/sh+316→ 52,185 total
  • Sale
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2010-03-12$40.88/sh−200→ 55,119 total
  • Exercise/Conversion
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2010-03-12$25.64/sh+1,001→ 56,870 total
  • Sale
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2010-03-12$40.88/sh−1,200→ 57,669 total
  • Sale
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2010-03-12$40.86/sh−1,500→ 56,169 total
  • Sale
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2010-03-12$40.87/sh−850→ 55,319 total
  • Sale
    Allergan Finance LLC

    Common Stock, par value $0.0033

    2010-03-12$40.85/sh−24,650→ 30,269 total
  • Exercise/Conversion
    Allergan Finance LLC

    Non-Qualified Options to Purchase Common Stock

    2010-03-12−6,400→ 0 total
  • Exercise/Conversion
    Allergan Finance LLC

    Incentive Stock Options to Purchase Common Stock

    2010-03-12−316→ 0 total
  • Exercise/Conversion
    Allergan Finance LLC

    Non-Qualified Options to Purchase Common Stock

    2010-03-12−1,999→ 0 total
  • Exercise/Conversion
    Allergan Finance LLC

    Incentive Stock Options to Purchase Common Stock

    2010-03-12−1,001→ 1,000 total

Companies

2

Recent Filings

13

Address

C/O WATSON PHARMACEUTICALS, INC. 311 BONNIE CIRCLE

CORONA, CA, 92880

View on SEC.gov